Cargando…

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study

Background: Carcinoembryonic antigen (CEA) is the most common serum tumor marker in colorectal cancer (CRC). Nevertheless, few previous studies demonstrated the impacts of postoperative CEA and post-preoperative CEA increment on prognosis of CRC. Methods: Patients with stage II and III CRC were incl...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Weiqiang, Yan, Li, Cai, Zerong, Xie, Lei, Sheng, Nengquan, Wang, Guiyu, Wu, Xiaojian, Wang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251078/
https://www.ncbi.nlm.nih.gov/pubmed/32509572
http://dx.doi.org/10.3389/fonc.2020.00671
_version_ 1783538887370473472
author You, Weiqiang
Yan, Li
Cai, Zerong
Xie, Lei
Sheng, Nengquan
Wang, Guiyu
Wu, Xiaojian
Wang, Zhigang
author_facet You, Weiqiang
Yan, Li
Cai, Zerong
Xie, Lei
Sheng, Nengquan
Wang, Guiyu
Wu, Xiaojian
Wang, Zhigang
author_sort You, Weiqiang
collection PubMed
description Background: Carcinoembryonic antigen (CEA) is the most common serum tumor marker in colorectal cancer (CRC). Nevertheless, few previous studies demonstrated the impacts of postoperative CEA and post-preoperative CEA increment on prognosis of CRC. Methods: Patients with stage II and III CRC were included from January 2009 to December 2015. All clinical and follow-up data were collected. Patients were divided into four different groups according to the levels of postoperative serum CEA and post-preoperative CEA trends. Chi-square test was used to analyze the relationship between clinical variables and categorized postoperative CEA and CEA increment. Cox proportional hazard regression was used for univariate and multivariable analyses. The log-rank test was performed to compare PFS and OS among groups. Results: Patients, 1,008, who underwent radical surgery, were enrolled. Our results showed that positive postoperative CEA and CEA increment were related to clinical stage, T stage, N stage, tumor differentiation, and lymphatic invasion (p < 0.05). Univariate and multivariable analysis results suggested that positive postoperative CEA and CEA increment were independent prognostic factors for PFS (HR = 3.149, 95% CI, 2.426–4.088, p = 0.000 for postoperative CEA; HR = 2.708, 95% CI, 2.106–3.482, p = 0.000 for CEA increment) and OS (HR = 3.414, 95% CI, 2.549–4.574, p = 0.000 for postoperative CEA; HR = 2.373, 95% CI, 1.783–3.157, p = 0.000 for CEA increment). The survival analyses revealed positive postoperative CEA, and CEA increment predicted worse prognosis. Furthermore, our results indicated that the 3- and 5-year PFS rates were 86.6 and 78.4% in group A, but decreased to 25.3 and 7.2% in group D (p < 0.001). Similarly, the 3- and 5-year OS rates for group A were 92.5 and 83.9%, much higher than group D (p < 0.001). In other words, patients with both postoperative CEA elevation and CEA increment had the worst prognosis. Conclusions: Positive postoperative CEA and CEA increment were independent prognostic factors for stage II and III CRC. Additionally, postoperative CEA and CEA increment had significant impacts on PFS and OS of CRC.
format Online
Article
Text
id pubmed-7251078
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72510782020-06-05 Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study You, Weiqiang Yan, Li Cai, Zerong Xie, Lei Sheng, Nengquan Wang, Guiyu Wu, Xiaojian Wang, Zhigang Front Oncol Oncology Background: Carcinoembryonic antigen (CEA) is the most common serum tumor marker in colorectal cancer (CRC). Nevertheless, few previous studies demonstrated the impacts of postoperative CEA and post-preoperative CEA increment on prognosis of CRC. Methods: Patients with stage II and III CRC were included from January 2009 to December 2015. All clinical and follow-up data were collected. Patients were divided into four different groups according to the levels of postoperative serum CEA and post-preoperative CEA trends. Chi-square test was used to analyze the relationship between clinical variables and categorized postoperative CEA and CEA increment. Cox proportional hazard regression was used for univariate and multivariable analyses. The log-rank test was performed to compare PFS and OS among groups. Results: Patients, 1,008, who underwent radical surgery, were enrolled. Our results showed that positive postoperative CEA and CEA increment were related to clinical stage, T stage, N stage, tumor differentiation, and lymphatic invasion (p < 0.05). Univariate and multivariable analysis results suggested that positive postoperative CEA and CEA increment were independent prognostic factors for PFS (HR = 3.149, 95% CI, 2.426–4.088, p = 0.000 for postoperative CEA; HR = 2.708, 95% CI, 2.106–3.482, p = 0.000 for CEA increment) and OS (HR = 3.414, 95% CI, 2.549–4.574, p = 0.000 for postoperative CEA; HR = 2.373, 95% CI, 1.783–3.157, p = 0.000 for CEA increment). The survival analyses revealed positive postoperative CEA, and CEA increment predicted worse prognosis. Furthermore, our results indicated that the 3- and 5-year PFS rates were 86.6 and 78.4% in group A, but decreased to 25.3 and 7.2% in group D (p < 0.001). Similarly, the 3- and 5-year OS rates for group A were 92.5 and 83.9%, much higher than group D (p < 0.001). In other words, patients with both postoperative CEA elevation and CEA increment had the worst prognosis. Conclusions: Positive postoperative CEA and CEA increment were independent prognostic factors for stage II and III CRC. Additionally, postoperative CEA and CEA increment had significant impacts on PFS and OS of CRC. Frontiers Media S.A. 2020-05-20 /pmc/articles/PMC7251078/ /pubmed/32509572 http://dx.doi.org/10.3389/fonc.2020.00671 Text en Copyright © 2020 You, Yan, Cai, Xie, Sheng, Wang, Wu and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
You, Weiqiang
Yan, Li
Cai, Zerong
Xie, Lei
Sheng, Nengquan
Wang, Guiyu
Wu, Xiaojian
Wang, Zhigang
Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title_full Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title_fullStr Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title_full_unstemmed Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title_short Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
title_sort clinical significances of positive postoperative serum cea and post-preoperative cea increment in stage ii and iii colorectal cancer: a multicenter retrospective study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251078/
https://www.ncbi.nlm.nih.gov/pubmed/32509572
http://dx.doi.org/10.3389/fonc.2020.00671
work_keys_str_mv AT youweiqiang clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT yanli clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT caizerong clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT xielei clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT shengnengquan clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT wangguiyu clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT wuxiaojian clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy
AT wangzhigang clinicalsignificancesofpositivepostoperativeserumceaandpostpreoperativeceaincrementinstageiiandiiicolorectalcanceramulticenterretrospectivestudy